Ha Kung Wong

Representative Matters

• Represented Alkermes against Luye Pharma on a patent related to injectable microsphere formulations for treatment of a variety of indications, including schizophrenia
• Represented Allergan against Wilshire, Somerset, and Aurobindo on patents related to ophthalmic formulations of alcaftadine, for once-daily treatment of allergic conjunctivitis
• Represented Alnylam against Silence Therapeutics on patents related to RNAi technology
• Represented Allergan against Prinston Pharmaceutical on patents related to tablet formulations of nebivolol hydrochloride and valsartan to treat hypertension
• Represented AstraZeneca against Andrx, Genpharm, Dr. Reddy, and Schwartz Pharma on patents related to omeprazole and its formulations
• Represented Bristol-Myers Squibb against the Regents of the University of Michigan, Repligen Corp., and ZymoGenetics on patents related to synthetic fusion proteins for regulating the immune system
• Represented UCB against Mylan, Dr. Reddy, Sandoz, and Cobalt on patents related to levetiracetam, a leading epilepsy medicine
• Represented GlaxoSmithKline against Barr Pharmaceuticals on patents related to dutasteride, a leading BPH drug
• Represented UCB and Celltech against KV Pharmaceutical on patents related to methylphenidate hydrochloride, an ADHD medicine

Representative Clients

• Alkermes
• Allergan
• Alnylam
• Bill & Melinda Gates Foundation and Gates MRI
• Materia
• Shionogi
• Stemline
• UCB

Education

• J.D. cum laude University of Notre Dame Law School 1999
• B.S. Chemistry high distinction University of Illinois Urbana-Champaign 1996
• B.S. Biochemistry University of Illinois Urbana-Champaign 1996

Bar Admissions

• New York

Court Admissions

• U.S. Supreme Court
• U.S. District Court for the Eastern District of New York
• U.S. District Court for the Southern District of New York
• U.S. Court of Federal Claims

Professional Memberships and Activities

• Board trustee, Foundation for Advancement of Diversity in IP Law (FADIPL)
• Vice president, Executive Committee Member & Board Trustee, Foundation for Advancement of Diversity in IP Law (FADIPL)
• Member, Venable Board
• Member, Advisory Board, Center for Biosimilars

• Managing Intellectual Property, IP Star, 2019 – 2020, 2022 – 2023
• National Law Journal, Elite Boutique Trailblazer, 2017 (Inaugural list)
• Client Choice Award, Intellectual Property, United States and New York, 2017 (Individual award)
• IAM Patent 1000, The World’s Leading Patent Professionals, 2018, 2021 – 2024
• LMG Life Sciences, Leading Lawyer, 2017 – 2020
• Super Lawyers,
  • Intellectual Property Litigation, New York Metro, 2023
  • Rising Star, Intellectual Property Litigation, New York Metro, 2012 – 2015
• Legal 500, Patent Litigation: Full Coverage, 2008 – 2009
• Lawline, Furthered 40
• Lawyers of Color, Law Firm Leaders, 2022

Volunteerism

• Volunteer mentor, College Admissions, UStrive Mentoring